Amarin Corp Plcuk (AMRN) Change in Receivables (2013 - 2026)

Amarin Corp Plcuk (AMRN) reported Change in Receivables of -$18.8 million for Q1 2026, down 20.82% year-over-year from -$23.7 million in Q1 2025, and down 3837.32% quarter-over-quarter from -$477000.0 in Q4 2025.

Amarin Corp Plcuk (AMRN) Change in Receivables (2013 - 2026) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 14 years of Change in Receivables data on file, last reported at -$18.8 million in Q1 2026.

  • Change in Receivables for Q1 2026 came in at -$18.8 million, down 20.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 114.52% YoY), and the FY2025 annual result was $4.6 million, up 140.35% from the prior year.
  • Change in Receivables fell to -$18.8 million in Q1 2026 per AMRN's latest filing, from -$477000.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $33.7 million in Q2 2022 and troughed at -$53.4 million in Q1 2022.
  • A 5-year average of -$3.3 million and a median of -$330000.0 in 2023 frame the typical range for Change in Receivables.
  • On a YoY basis, Change in Receivables climbed as much as 175.05% in 2024 and fell as far as 3248.18% in 2024.
  • A 5-year view of Change in Receivables shows it stood at $7.6 million in 2022, then jumped by 46.67% to $11.2 million in 2023, then slipped by 13.67% to $9.6 million in 2024, then tumbled by 104.95% to -$477000.0 in 2025, then slumped by 3837.32% to -$18.8 million in 2026.
  • Business Quant data shows AMRN's Change in Receivables at -$18.8 million in Q1 2026, -$477000.0 in Q4 2025, and $8.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 595.00 Mn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn -87.00 Mn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn -413.00 Mn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn -134.00 Mn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn -
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -1.69 Bn
10 Amarin Corp Plcuk 6.77 Bn 6.59 Bn 17.77 Mn -18.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.78 Mn
Mar 31, 2026 -18.78 Mn
Dec 31, 2025 -477,000.00
Dec 31, 2025 -477,000.00
Sep 30, 2025 8.18 Mn
Sep 30, 2025 8.18 Mn
Jun 30, 2025 12.40 Mn
Jun 30, 2025 12.40 Mn
Mar 31, 2025 -15.55 Mn
Mar 31, 2025 -15.55 Mn
Dec 31, 2024 9.64 Mn
Dec 31, 2024 9.64 Mn
Sep 30, 2024 -11.05 Mn
Sep 30, 2024 -11.05 Mn
Jun 30, 2024 7.89 Mn
Jun 30, 2024 7.89 Mn
Mar 31, 2024 -17.76 Mn
Mar 31, 2024 -17.76 Mn
Dec 31, 2023 11.16 Mn
Dec 31, 2023 11.16 Mn